The New Energy Crisis No One Saw Coming
Free investor report reveals how the electric car initiative is putting the U.S. in peril...and shows how to potentially capitalize on this crisis with a junior mining company.
See how this new energy crisis could create a boom

RAIN Insider Trading

Insider Ownership Percentage: 21.90%
Insider Buying (Last 12 Months): $15,990,383.10
Insider Selling (Last 12 Months): $0.00

Rain Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Rain Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rain Therapeutics Share Price & Price History

Current Price: $6.79
Price Change: Price Decrease of -0.04 (-0.59%)
As of 12/6/2022 04:59 PM ET

This chart shows the closing price history over time for RAIN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Rain Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2022Franklin M. BergerDirectorBuy45,000$7.80$351,000.00928,207View SEC Filing Icon  
11/8/2022Bvf Partners L P/IlInsiderBuy1,710,358$5.83$9,971,387.142,870,985View SEC Filing Icon  
11/4/2022Aaron I DavisDirectorBuy972,212$5.83$5,667,995.962,147,212View SEC Filing Icon  
10/11/2021Perceptive Advisors LlcMajor ShareholderSell21,826$12.51$273,043.26View SEC Filing Icon  
10/7/2021Perceptive Advisors LlcMajor ShareholderSell13,368$14.81$197,980.08View SEC Filing Icon  
9/21/2021Franklin M. BergerDirectorBuy3,786$14.30$54,139.80View SEC Filing Icon  
9/13/2021Bvf Partners L P/IlDirectorBuy392,269$16.49$6,468,515.81View SEC Filing Icon  
7/6/2021Bvf Partners L P/IlDirectorBuy269,723$15.25$4,113,275.75View SEC Filing Icon  
7/1/2021Bvf Partners L P/IlDirectorBuy317,279$15.65$4,965,416.35View SEC Filing Icon  
5/24/2021Bvf Partners L P/IlDirectorBuy1,361$15.90$21,639.90View SEC Filing Icon  
5/21/2021Bvf Partners L P/IlDirectorBuy121,986$15.94$1,944,456.84View SEC Filing Icon  
5/13/2021Bvf Partners L P/IlDirectorBuy58,000$14.26$827,080.00View SEC Filing Icon  
4/27/2021Boxer Capital, LlcDirectorBuy1,025,000$17.00$17,425,000.00View SEC Filing Icon  
4/27/2021Perceptive Advisors LlcMajor ShareholderBuy550,000$17.00$9,350,000.00View SEC Filing Icon  
4/23/2021Boxer Capital, LlcDirectorBuy150,000$16.16$2,424,000.00120,000View SEC Filing Icon  
See Full Table
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War
Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump...
China's Monopoly Is About To Crumble...

SEC Filings (Institutional Ownership Changes) for Rain Therapeutics (NASDAQ:RAIN)

52.77% of Rain Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RAIN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Rain Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Jacobs Levy Equity Management Inc.22,635$0.11M0.0%N/A0.085%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.137,943$0.67M0.0%-2.9%0.520%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC67,250$0.33M0.0%+549.0%0.253%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC22,000$0.11M0.0%+46.7%0.083%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC65,096$0.32M0.0%-7.9%0.245%Search for SEC Filing on Google Icon
11/14/2022UBS Oconnor LLC326,451$1.59M0.0%-2.0%1.230%Search for SEC Filing on Google Icon
11/10/2022Credit Suisse AG18,000$88K0.0%+224,900.0%0.068%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.10,072$56K0.0%-39.5%0.038%Search for SEC Filing on Google Icon
8/16/2022Thrivent Financial for Lutherans28,401$0.16M0.0%+79.9%0.107%Search for SEC Filing on Google Icon
8/15/2022State Street Corp23,458$0.13M0.0%-87.8%0.088%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP313,200$1.74M0.0%N/A1.181%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC29,405$0.16M0.0%+18.6%0.111%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC15,000$83K0.0%N/A0.057%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp14,530$80K0.0%-88.1%0.055%Search for SEC Filing on Google Icon
8/12/2022FMR LLC255,887$1.42M0.0%-30.7%0.965%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.16,655$84K0.0%+65.9%0.063%Search for SEC Filing on Google Icon
5/16/2022State Street Corp191,801$0.97M0.0%+42.0%0.724%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp121,824$0.62M0.0%+69.0%0.460%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.521,033$2.64M0.0%+2.7%1.965%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.803,211$4.07M0.0%+8.4%3.030%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.9,615$49K0.0%-32.5%0.036%Search for SEC Filing on Google Icon
5/4/2022Victory Capital Management Inc.98,480$0.50M0.0%-5.2%0.371%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC2,483,619$31.99M0.5%-2.1%9.384%Search for SEC Filing on Google Icon
2/8/2022First Trust Advisors LP12,159$0.16M0.0%+14.1%0.046%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp72,097$0.93M0.0%+3.4%0.272%Search for SEC Filing on Google Icon
2/7/2022Victory Capital Management Inc.103,910$1.34M0.0%-8.9%0.393%Search for SEC Filing on Google Icon
1/20/2022Parallel Advisors LLC11,512$0.15M0.0%+3,737.3%0.043%Search for SEC Filing on Google Icon
11/16/2021Janus Henderson Group PLC1,402,074$20.46M0.0%-3.5%5.297%Search for SEC Filing on Google Icon
11/16/2021BVF Inc. IL2,957,807$44.25M1.7%+52.0%11.175%Search for SEC Filing on Google Icon
11/15/2021Luminus Management LLC137,428$2.06M0.4%-67.7%0.519%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC129,951$1.94M0.0%+1.7%0.491%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.372,747$5.58M0.0%+4.2%1.408%Search for SEC Filing on Google Icon
11/2/2021Victory Capital Management Inc.114,090$1.71M0.0%-0.8%0.431%Search for SEC Filing on Google Icon
10/18/2021Nisa Investment Advisors LLC14,286$0.21M0.0%N/A0.054%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP119,700$1.86M0.0%N/A0.452%Search for SEC Filing on Google Icon
8/17/2021Zimmer Partners LP10,000$0.16M0.0%N/A0.038%Search for SEC Filing on Google Icon
8/17/2021Perceptive Advisors LLC2,537,019$39.43M0.5%N/A9.580%Search for SEC Filing on Google Icon
8/17/2021Samsara BioCapital LLC1,637,308$25.44M3.1%N/A6.182%Search for SEC Filing on Google Icon
8/17/2021Logos Global Management LP780,331$12.13M1.0%N/A2.947%Search for SEC Filing on Google Icon
8/17/2021Acuta Capital Partners LLC162,245$2.52M1.0%N/A0.613%Search for SEC Filing on Google Icon
8/17/2021BVF Inc. IL1,945,949$30.24M1.1%N/A7.348%Search for SEC Filing on Google Icon
8/17/2021Boxer Capital LLC1,175,000$18.26M0.6%N/A4.437%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System10,258$0.16M0.0%N/A0.039%Search for SEC Filing on Google Icon
8/16/2021Perceptive Advisors LLC2,537,019$39.43M0.5%N/A9.580%Search for SEC Filing on Google Icon
8/16/2021Alyeska Investment Group L.P.175,000$2.72M0.0%N/A0.661%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.18,897$0.29M0.0%N/A0.071%Search for SEC Filing on Google Icon
8/16/2021State Street Corp89,135$1.39M0.0%N/A0.337%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC11,617$0.18M0.0%N/A0.044%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp76,272$1.19M0.0%N/A0.288%Search for SEC Filing on Google Icon
8/13/2021Lumina Fund Management LLC6,000$93K0.0%N/A0.023%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC127,718$1.98M0.0%N/A0.482%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.364,328$5.66M0.0%N/A1.376%Search for SEC Filing on Google Icon
8/13/2021FMR LLC800,000$12.43M0.0%N/A3.021%Search for SEC Filing on Google Icon
8/12/2021Advisory Services Network LLC2,300$36K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.2,849$44K0.0%N/A0.011%Search for SEC Filing on Google Icon
8/12/2021Monashee Investment Management LLC20,000$0.31M0.0%N/A0.076%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp13,447$0.21M0.0%N/A0.051%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.357,588$5.56M0.0%N/A1.350%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG4,405$68K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/3/2021Victory Capital Management Inc.114,980$1.79M0.0%N/A0.434%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Rain Therapeutics logo
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinical trial for intimal sarcoma, as well as RAD52 which is in preclinical trials for tumors, including breast, ovarian, pancreatic, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.
Read More on Rain Therapeutics

Today's Range

Now: $6.79
Low: $6.45
High: $7.33

50 Day Range

MA: $5.98
Low: $3.94
High: $8.48

52 Week Range

Now: $6.79
Low: $2.15
High: $14.49

Volume

1,926 shs

Average Volume

111,052 shs

Market Capitalization

$180.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.01

Who are the company insiders with the largest holdings of Rain Therapeutics?

Rain Therapeutics' top insider shareholders include:
  1. Bvf Partners L P/Il (Insider)
  2. Aaron I Davis (Director)
  3. Franklin M Berger (Director)
  4. Boxer Capital, Llc (Director)
  5. Bvf Partners L P/Il (Director)
  6. Cormorant Asset Management, Lp (Insider)
  7. Perceptive Advisors Llc (Major Shareholder)
  8. Value Fund L P Biotechnology (Insider)
Learn More about top insider investors at Rain Therapeutics.

Who are the major institutional investors of Rain Therapeutics?

Rain Therapeutics' top institutional investors include:
  1. UBS Oconnor LLC — 1.23%
  2. BlackRock Inc. — 0.52%
  3. Citadel Advisors LLC — 0.25%
  4. Ergoteles LLC — 0.25%
  5. Jacobs Levy Equity Management Inc. — 0.09%
  6. Renaissance Technologies LLC — 0.08%
Learn More about top institutional investors of Rain Therapeutics stock.

Which institutional investors are selling Rain Therapeutics stock?

Within the previous quarter, RAIN stock was sold by these institutional investors:
  1. UBS Oconnor LLC
  2. Ergoteles LLC
  3. BlackRock Inc.

Which institutional investors are buying Rain Therapeutics stock?

In the previous quarter, RAIN stock was purchased by institutional investors including:
  1. Citadel Advisors LLC
  2. Jacobs Levy Equity Management Inc.
  3. Credit Suisse AG
  4. Renaissance Technologies LLC
During the last year, these company insiders have bought Rain Therapeutics stock:
  1. Bvf Partners L P/Il (Insider)
  2. Aaron I Davis (Director)
  3. Franklin M Berger (Director)
  4. Boxer Capital, Llc (Director)
  5. Bvf Partners L P/Il (Director)
  6. Cormorant Asset Management, Lp (Insider)
  7. Perceptive Advisors Llc (Major Shareholder)
  8. Value Fund L P Biotechnology (Insider)
Learn More investors buying Rain Therapeutics stock.
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War
Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump...
China's Monopoly Is About To Crumble...